HC Wainwright & Co. Reiterates Buy on Tenaya Therapeutics, Maintains $18 Price Target

Benzinga · 10/18 10:50
HC Wainwright & Co. analyst Joseph Pantginis reiterates Tenaya Therapeutics (NASDAQ:TNYA) with a Buy and maintains $18 price target.